Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-intervention Follow-up of the Allergy Reduction Trial, to Investigate the Prolonged Risk Reducing Effect of a Partially Hydrolysed Infant Formula During the First Six Months of Life on Allergic Manifestations Up to the Age of 5 Years

NCT05418491 is registered in ClinicalTrials.gov with FrieslandCampina as lead sponsor.

NCT NCT05418491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05418491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-intervention Follow-up of the Allergy Reduction Trial, to Investigate the Prolonged Risk Reducing Effect of a Partially Hydrolysed Infant Formula During the First Six Months of Life on Allergic Manifestations Up to the Age of 5 Years
Lead sponsor
FrieslandCampina
Phase
Observational
Overall status
Completed
Start date
July 21, 2022
Completion date
July 31, 2024
Enrollment
455 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

allergy